LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹602 Cr | ₹666 Cr | ₹994 Cr | ₹911 Cr | ₹733 Cr |
What is the latest Cash Flow from Operating Activities ratio of LAURUS LABS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹602 Cr |
Mar2024 | ₹666 Cr |
Mar2023 | ₹994 Cr |
Mar2022 | ₹911 Cr |
Mar2021 | ₹733 Cr |
How is Cash Flow from Operating Activities of LAURUS LABS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹602 Cr | -9.62 | |
Mar2024 | ₹666 Cr | -33.02 | |
Mar2023 | ₹994 Cr | 9.09 | |
Mar2022 | ₹911 Cr | 24.30 | |
Mar2021 | ₹733 Cr | - |
Compare Cash Flow from Operating Activities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹40,880.1 Cr | 11.3% | 22.3% | 75.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,584.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,147.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹120,941.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,325.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,138.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | 11.3% |
22.3% |
75.8% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses